Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
February 24, 2021Frontiers in ImmunologyOpen Access

Two Different Antibody-Dependent Enhancement (ADE) Risks for SARS-CoV-2 Antibodies

View Full Paper
Ask AI
Bookmark
Share

Authors

DRDarrell Ricke

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Darrell Ricke (2021) studied this question.

synapsesocial.com/papers/6aa9fab069cd2ab2e5a4dab7https://doi.org/10.3389/fimmu.2021.640093
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Emerging coronaviruses: Genome structure, replication, and pathogenesis2020 · 762 citations
  2. 2Viral-Induced Enhanced Disease Illness2018 · 138 citations
  3. 3Immunization with SARS Coronavirus Vaccines Leads to Pulmonary Immunopathology on Challenge with the SARS Virus2012 · 609 citations
  4. 4SARS-CoV-2 neutralizing antibody levels are correlated with severity of COVID-19 pneumonia2020 · 73 citations
  5. 5Emerging coronaviruses: Genome structure, replication, and pathogenesis2020 · 3,174 citations